Skip to main content
. 2008 Aug 5;99(4):577–583. doi: 10.1038/sj.bjc.6604499

Figure 1.

Figure 1

Kaplan–Meier curves for (A) overall survival (n=29) and (B) time to progression (n=27) for patients treated at the MTD, and (C) overall survival (n=45) and (D) time to progression (n=40) for all patients in the phase I/II study.